@SiskaVB

Urologist. Life enthusiast.

 Kortrijk, België
Joined January 2015
  • Tweets230
  • Following62
  • Followers475
58Media
Siska Van Bruwaene retweeted
Declan Murphy@declangmurphy4 Apr 2024
Replying to @SiskaVB @EveraertsW @piet_ost @shanekronos
It’s quite amazing!! PLND appears to have disappeared from the updated Prostate Cancer #EAUGuidelines! Now aligns with practice in Australia 10 years into the PSMA era #EAU24 – at Louvres, France
1
3
10
876
Siska Van Bruwaene retweeted
Alexander Kutikov MD
@uretericbud26 May 2023
🔬💊 #TherapeuticNodeYield ➡️ #WillRogers 🤠 + #BiasMirage 🔮 as long anticipated pubmed.ncbi.nlm.nih.gov/3657… @KBGinsburg #ASCO23

The Phenomenon of "Therapeutic" Nodal Yield at Cystectomy for Bladder Cancer: Do Not Discount the...

A strategy to dissect a high number of lymph nodes in patients undergoing removal of their bladder for bladder cancer can be associated with side effects, and the benefit in terms of cancer control...

pubmed.ncbi.nlm.nih.gov
1
1
12
2,426
Siska Van Bruwaene retweeted
Alexander Kutikov MD
@uretericbud26 May 2023
🔬ePLND in #BladderCancer 🏥 😞 More harm. ❌Zero benefit 📚Level I evidence from @SWOG👩‍⚕️👨‍⚕️ meetings.asco.org/abstracts-… (tnx @KBGinsburg for alway being the first to find the good stuff!) #ASCO23 @ASCO
1
30
2
88
15,379
Siska Van Bruwaene retweeted
Matt Cooperberg
@dr_coops12 Mar 2023
ProtecT 15 yr: ⁦@Freddie_Hamdy⁩ taking on misconceptions, and conclusions. #eau23 Thoughts #pcsm??
10
40
113
20,471
Siska Van Bruwaene retweeted
Murat Akand@muratakand0622 Dec 2022
Check out our latest paper on "Quality Control Indicators for TURBT" #bladdercancer @EurUrolOncol authors.elsevier.com/c/1gHHb… @CaBLe_UZL @TimMuilwijk @FrankVanderAa6 @joniau @yraskin @SiskaVB @KathyVanderEeckt @BenVanCleynenbreugel @CedricJorissen @UZLeuven @VznkuL
4
26
2,349
Siska Van Bruwaene retweeted
Alastair Lamb@LambAlastair12 Mar 2023
15yr f/u for #ProtecT_Trial just out! •n=1610 •1/3 IR or HR by NCCN criteria •n=45 DS deaths (AM17:RP12:RT16) •n=104 mets (AM51:RP26:RT27) •n=151 started ADT (AM69:RP40:RT42) •62% of AS cross over to radical Surprised? Or no surprises?? #EAU23 #Oxford_Urology @BAUSurology
5
50
128
30,243
Siska Van Bruwaene retweeted
Alastair Lamb@LambAlastair13 Mar 2023
Guess this is key slide from Freddie's talk. It's given me a bit of an existential crisis over past 36hrs Should we approach all localised #ProstateCancer like we now do salvageRT? i.e. put EVERYONE on surveillance, then only treat those who 'progress'?? (1/3 were T3!) #EAU23
15
32
4
129
36,434
Siska Van Bruwaene retweeted
Andries Clinckaert@andries_c18 Nov 2022
Lymphedema after prostate cancer treatment? For many, it remains the forgotten vascular disease. 👉 Find out in our systematic review mdpi.com/1953218 #mdpicancers via @Cancers_MDPI @joniau @EveraertsW @LisaMoris2
1
4
10
Siska Van Bruwaene retweeted
UroToday.com
@urotoday27 Oct 2022
When low-volume on conventional imaging goes into high-volume on next-generation imaging in #mHSPC - treat like low-volume. #APCCC22 presentation by @fizazi_karim @GustaveRoussy. #ReadNow on UroToday > bit.ly/3RgVCLs @APCCC_Lugano @Silke_Gillessen @AOmlin
5
4
Siska Van Bruwaene retweeted
Shankar Siva
@_ShankarSiva25 Oct 2022
Late breaking abstracts #ASTRO22 - @ChadTangMD EXTEND trial; oligometastatic #prostatecancer. Intermittent ADT + SABR versus ADR alone extends PFS, but importantly time men enjoy off ADT in the long term (eugonadal PFS). Important patient centric endpoint! 👏🏽⭐️ @OncoAlert #pcsm
8
96
3
243
@Prof_Nick_James on the association between volume & radiotherapy in #metastaticprostatecancer Is 4 the magic no for mets? How important is LN burden? Can men with mets be cured? 🤔 #PROSCA22 @mirrorsmed
1
3
9
Just when you thought to grasp oligo-metastatic disease …@juliarmurray helping to see the light #PROSCA22
6
D2 #PROSCA22 in beautiful Athens @Silke_Gillessen outlines the evidence for #docetaxel in #mHSPC Is volume of disease important? Does it matter if synchronous v metachronous disease? Triple v doublet therapy? @mirrorsmed @Prof_Nick_James
1
9
1
19
Amit Bahl warning to perform imaging in mCRPC even when PSA is stable. #PROSCA22
1
7
Some Stampede high risk patients might be cured with surgery alone instead of ‘suffering’ 2 years of intensified hormonal treatment. #PROSCA22 @joniau excellent talk
5
11
Great talk by @EricKleinMD Genomics in PCa might help us to look under the surface. #PROSCA22
1
1
7
When will these tests become readily available in Europe?
Stuck on the island of Milos (no boats back). But ready for #PROSCA22 @mirrorsmed 💪
2
1
20
Siska Van Bruwaene retweeted
Valérie Fonteyne@fontev124 Sep 2022
WPRT or PORT for pN1 PCa: first results of the PROPER trial reveal: - difficulties to recruit patients - no pelvic recurrences but more acute grade 2 GI toxicity with WPRT @Stkstichting
2
17
1
42
Siska Van Bruwaene retweeted
Dr Ward Sam
@dr_wardsam4 Dec 2021
“Always rule out bladder cancer when patients are presenting with over active bladder amd not respond to symptomatic treatment.” MD Van den Broeck Thomas presenting at #BAU21 @BVUrologie @sb_uro @Uroweb @joniau @SiskaVB @PieterUvin “use narrow band imaging/blue light & cytology” – at Louvain, Belgium
6
13
Load more